Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1403 Records) |
| Query Trace: Ovarian Neoplasms and BRCA1[original query] |
|---|
| Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland. International journal of molecular sciences 2023 9 24 (17): . Tadeusz Ka?u?ewski, Izabela Kubiak, Micha? Bednarek, Jordan Sa?amunia, Dorota Kucharska, ?ukasz K?pczy?ski, Marek Stempie?, Tobiasz Kubicki, Radzis?aw Trzci?ski, Zofia Gordon-Sönmez, Anna Bartosi?ska-Dyc, Agnieszka Gach, Bogdan Ka?u?ews |
| Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru. Frontiers in oncology 2023 9 13 1227864. Yomali Ferreyra, Gina Rosas, Alicia M Cock-Rada, Jhajaira Araujo, Leny Bravo, Franco Doimi, Jhoysi Casas, María de Los Ángeles Clavo, Joseph A Pinto, Carolina Belmar-Lóp |
| Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients. Frontiers in oncology 2023 9 13 1221096. Alberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, Gianluca Tedaldi, Claudia Casanova, Valentina Arcangeli, Andrea Amadori, Marta Rosati, Marco Stefanetti, Salvatore Luca Burgio, Maria Concetta Cursano, Cristian Lolli, Valentina Zampiga, Ilaria Cangini, Giuseppe Schepisi, Ugo De Gior |
| BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer. The journal of obstetrics and gynaecology research 2023 9 . Akkamahadevi Patil, Sharada Patil, C E Anupama, Savitha Rajarajan, Vidya P Nimbalkar, Usha Amirtham, G Champaka, M N Suma, Geetha V Patil, Ashwini Nargund, V R Pallavi, Linu Jacob, C S Premalatha, Jyothi S Prab |
| A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score. Frontiers in genetics 2023 9 14 1240068. Fan Yang, Wei Wei, Ganghua Li, Qiongyu Lan, Xiwei Liu, Lin Gao, Chao Zhang, Jiangtao Fan, Jundong |
| The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer. Oncology and therapy 2023 9 . Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kass |
| Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer. Journal of community genetics 2023 9 . Silvia Actis, Marta D'Alonzo, Luca Pace, Serena Mucciacito, Valentina Elisabetta Bounous, Luca Giuseppe Sgrò, Matteo Mancarella, Annamaria Ferrero, Nicoletta Bigl |
| SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma. Molecular cancer therapeutics 2023 9 . Hidehiko Akashi, Nozomi Yachida, Haruka Ueda, Manako Yamaguchi, Kaoru Yamawaki, Ryo Tamura, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi, Yoshikazu Nagase, Yutaka Ueda, Masashi Ueda, Kaoru Abiko, Masahiro Kagabu, Tsukasa Baba, Hirofumi Nakaoka, Takayuki Enomoto, Junko Murai, Kosuke Yoshiha |
| Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023 8 . Ok-Ju Kang, Shin-Wha Lee, Ju-Hyun Kim, Jeong-Yeol Park, Dae-Shik Suh, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak K |
| Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. Gynecologic oncology 2023 8 177 72-85. Priyanka Narayan, Muhammad Danyal Ahsan, Emily M Webster, Luiza Perez, Sarah R Levi, Benedict Harvey, Isabel Wolfe, Shanice Beaumont, Jesse T Brewer, Drew Siegel, Charlene Thomas, Paul Christos, Andy Hickner, Eloise Chapman-Davis, Evelyn Cantillo, Kevin Holcomb, Ravi N Sharaf, Melissa K Fr |
| Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 2023 8 7 e2200695. Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke Lucassen, Nadine M Tung, Claudine Isaa |
| Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers. JCO precision oncology 2023 8 7 e2300036. Dylane Wineland, Anh N Le, Ryan Hausler, Gregory Kelly, Emanuel Barrett, Heena Desai, Bradley Wubbenhorst, John Pluta, Paul Bastian, Heather Symecko, Kurt D'Andrea, Abigail Doucette, Peter Gabriel, Kim A Reiss, Anupma Nayak, Michael Feldman, Susan M Domchek, Katherine L Nathanson, Kara N Maxwell, , |
| Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Breast cancer research and treatment 2023 8 . Aysun Dauti Isiklar, Lamiya Aliyeva, Ahmet Yesilyurt, Aykut Soyder, Gul Basar |
| Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes. Breast cancer research and treatment 2023 8 . Lauren Lenz, Chris Neff, Cara Solimeno, Elizabeth S Cogan, Vandana G Abramson, Judy C Boughey, Carla Falkson, Matthew P Goetz, James M Ford, William J Gradishar, Rachel C Jankowitz, Virginia G Kaklamani, P Kelly Marcom, Andrea L Richardson, Anna Maria Storniolo, Nadine M Tung, Shaveta Vinayak, Darren R Hodgson, Zhongwu Lai, Simon Dearden, Bryan T Hennessy, Erica L Mayer, Gordon B Mills, Thomas P Slavin, Alexander Gutin, Roisin M Connolly, Melinda L Telli, Vered Stearns, Jerry S Lanchbury, Kirsten M Tim |
| Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers. Cancers 2023 8 15 (15): . Dominik Dannehl, Tobias Engler, Léa Louise Volmer, Christian Martin Tegeler, Julia Fusshoeller, Emma Gabrysch, Kenneth Eissler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Ines Gruber, Fabienne Schochter, Kerstin Pfister, Kristina Veselinovic, Elena Leinert, Brigitte Rack, Visnja Fink, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Henning Schäffl |
| Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers. JAMA network open 2023 7 6 (7): e2326437. Hao Wen, Qin Xu, Xiujie Sheng, Huawen Li, Xipeng Wang, Xiaohua |
| Germline mutations in 32 cancer susceptibility genes by Next-Generation Sequencing among breast cancer patients. Oncology 2023 7 . Yu Yang, Chang Liu, Zhong-Ling Zhuo, Fei Xie, Ke Wang, Shu Wang, Xiao-Tao Zh |
| Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program. Gynecologic oncology reports 2023 7 48 101211. Alfonso Yubero, Purificación Estévez, Aránzazu Barquín, Luisa Sánchez, Ana Santaballa, Bella Pajares, Piedad Reche, Carmen Salvador, Luis Manso, Raúl Márquez, Antonio González-Mart |
| Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer. International journal of molecular sciences 2023 7 24 (14): . Edith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, Patricia Pautier, Ludovic Lacroix, Sandrine M Caputo, Odile Cabaret, Marine Guillaud-Bataille, Judith Michels, Aurelie Auguste, Alexandra Leary, Etienne Roule |
| Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 7 . Joanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, Lauren R Teras, Alpa V Patel, Chunling Hu, Siddhartha Yadav, Fergus J Couch, Shelley S Tworog |
| Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study. Scientific reports 2023 7 13 (1): 11962. Ryota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, Keisuke Seto, Ryoko Udagawa, Yoshimasa Saito, Hironobu Hashimoto, Tatsunori Shimoi, Kan Yonemori, Masahito Yonemura, Hiroyuki Terakado, Takahiro Nishimura, Toshikatsu Kawasaki, Tetsuya Furukawa, Tomonori Nakamu |
| [GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN]. Harefuah 2023 7 162 (6): 370-375. Rachel Michaelson-Cohen, Yael Laitman, Inbal Kedar, Hagit Baris-Feldman, Orit Reish, Sari Lieberman, Rinat Bernstein-Molho, Yael Goldberg, Gili Reznick Levi, Ruth Gershoni, Uzi Beller, Ephrat Levy-Lahad, Raphael Catan, Eitan Friedm |
| Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling. Mutation research 2023 7 827 111831. Zeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzo?lu, Mutlu Do?an, Öztürk Ate?, Ece Esin, ?rem Bilgetekin, Umut Demirci, Ça?lar Köseo?lu, Alper Topal, Nuri Karadurmu?, Haktan Ba??? Erdem, Taha Bah |
| Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort. Cancers 2023 7 15 (13): . Ahmed Bouras, Souhir Guidara, Mélanie Leone, Adrien Buisson, Tanguy Martin-Denavit, Sophie Dussart, Christine Lasset, Sophie Giraud, Marie-Noëlle Bonnet-Dupeyron, Zine-Eddine Kherraf, Damien Sanlaville, Sandra Fert-Ferrer, Marine Lebrun, Valerie Bonadona, Alain Calender, Nadia Boutry-Kry |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. Translational lung cancer research 2023 7 12 (6): 1236-1244. Ju-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, Jennifer J D Morrissette, Katherine L Nathanson, Roger B Cohen, Jason N Rosenba |
| CA125 Levels in BRCA mutation carriers - a retrospective single center cohort study. BMC cancer 2023 7 23 (1): 610. P Gebhart, C F Singer, D Gschwantler-Kauli |
| Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP. Climacteric : the journal of the International Menopause Society 2023 6 1-8. R F M Vermeulen, J L van Altena, K N Gaarenstroom, M van Beurden, J K Kieffer, N K Aaronson, G G Kenter, C M Kor |
| Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles. Nature communications 2023 6 14 (1): 3350. Kevin Elias, Urszula Smyczynska, Konrad Stawiski, Zuzanna Nowicka, James Webber, Jakub Kaplan, Charles Landen, Jan Lubinski, Asima Mukhopadhyay, Dona Chakraborty, Denise C Connolly, Heather Symecko, Susan M Domchek, Judy E Garber, Panagiotis Konstantinopoulos, Wojciech Fendler, Dipanjan Chowdhu |
| Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients. Cancers 2023 6 15 (11): . Egija Berga-Šv?ti?a, Je?ena Maksimenko, Edv?ns Miklaševi?s, Krista Fischer, Baiba Vilne, Reedik Mä |
| Homologous Recombination Deficiency Score Determined by Genomic Instability in a Romanian Cohort. Diagnostics (Basel, Switzerland) 2023 6 13 (11): . Viorica-Elena R?doi, Mihaela ?urcan, Ovidiu Virgil Maioru, Andra Dan, Laurentiu Camil Bohîl?ea, Elena Adriana Dumitrescu, Adelina Silvana Gheorghe, Dana Lucia St?nculeanu, Georgia Thodi, Yannis L Loukas, Ileana-Delia S?b |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: